Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
COSMO Pharmaceuticals N.V. ( (CH:COPN) ) has provided an update.
Cosmo Pharmaceuticals N.V. has appointed Federico Sommariva as its new Chief Legal Counsel. With extensive experience in the life sciences industry, Sommariva is expected to guide the company through regulatory challenges and support its strategic growth. His appointment is seen as a significant addition to Cosmo’s leadership team, enhancing its capability to navigate the evolving legal landscape and achieve long-term objectives.
More about COSMO Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V. is a pharmaceutical company focused on revolutionizing healthcare by developing innovative products that address unmet needs in areas such as Healthtech/AI, Dermatology, and Gastroenterology. The company collaborates with global partners like Medtronic and Sun Pharma for product commercialization and distribution. Founded in 1997, Cosmo is headquartered in Dublin, Ireland, and employs around 330 people.
YTD Price Performance: -9.99%
Average Trading Volume: 574
Technical Sentiment Signal: Buy
Current Market Cap: CHF964.8M
See more insights into COPN stock on TipRanks’ Stock Analysis page.